Induction of IgG antibodies against GD3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody

P B Chapman, A N Houghton, P B Chapman, A N Houghton

Abstract

Anti-idiotypic MAb were raised in syngeneic mice against a mouse MAb recognizing GD3 ganglioside (MAb R24). Two anti-idiotypic MAb, designated BEC2 and BEC3, recognized distinct determinants on MAb R24 that mapped near or within the GD3-binding site. New Zealand white rabbits, which express GD3 on normal tissues, were immunized with either BEC2, BEC3, or control MAb FLOPC-21. All rabbits developed high and equivalent titers of antibodies against mouse immunoglobulins. Immunization with BEC2 and BEC3 induced rabbit antibodies expressing R24 idiotype as demonstrated by their ability to inhibit BEC2 binding to R24. Antibodies (IgG and IgM) reacting with GD3 developed in five of eight rabbits immunized with BEC2 but not in rabbits immunized with BEC3 or with control MAb. Serum antibodies against GD3 did not cross-react with other gangliosides. These results show that MAb BEC2 can mimic GD3 ganglioside and can induce antibodies against GD3 ganglioside despite expression of GD3 on normal rabbit tissue.

References

    1. Ann Immunol (Paris). 1974 Jan;125C(1-2):373-89
    1. Cancer Res. 1990 Mar 1;50(5):1503-9
    1. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6114-8
    1. J Neurochem. 1980 Jan;34(1):184-8
    1. Biochim Biophys Acta. 1981 Aug 24;665(2):214-20
    1. J Exp Med. 1982 Dec 1;156(6):1884-9
    1. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7629-33
    1. Proc Natl Acad Sci U S A. 1983 Sep;80(17):5392-6
    1. J Exp Med. 1983 Oct 1;158(4):1129-44
    1. J Immunol. 1984 Apr;132(4):1793-7
    1. J Exp Med. 1984 Oct 1;160(4):1001-11
    1. Science. 1984 Dec 14;226(4680):1325-6
    1. Brain Res. 1984 Dec 17;324(1):190-4
    1. Immunol Lett. 1984;8(5):273-7
    1. Int J Cancer. 1985 May 15;35(5):607-12
    1. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5155-9
    1. Cancer Res. 1985 Sep;45(9):4401-11
    1. J Biochem. 1985 Apr;97(4):1219-27
    1. Science. 1986 Apr 4;232(4746):100-2
    1. J Exp Med. 1987 Mar 1;165(3):812-29
    1. J Immunol. 1987 Sep 15;139(6):1763-71
    1. J Clin Invest. 1987 Nov;80(5):1217-24
    1. Arch Biochem Biophys. 1988 Jan;260(1):51-5
    1. J Clin Oncol. 1988 Oct;6(10):1636-48
    1. Cancer Res. 1989 Jan 1;49(1):191-6
    1. Cancer Res. 1989 Dec 15;49(24 Pt 1):7045-50
    1. J Immunol. 1989 Dec 15;143(12):4338-44
    1. J Immunol. 1990 Feb 1;144(3):1023-9
    1. Infect Immun. 1990 Feb;58(2):416-20
    1. Biochim Biophys Acta. 1978 Feb 27;528(2):257-67

Source: PubMed

3
Abonnere